•  
  •  
 

Subject Area

Cardiology

Article Type

Original Study

Abstract

Objectives to study the Clinical features and outcome of patients presented with ST-Segment Elevation Myocardial Infarction (STEMI) and concomitant COVID-19 infection treated by primary percutaneous coronary intervention Background Primary Percutaneous Coronary Intervention (pPCI) is considered the preferred recommended tool for emergency revascularization of patients with STEMI. Methods This study was conducted on 50 patients presented with presented by STEMI within 24 hours of symptoms onset with and without concomitant COVID 19 infections treated by primary Percutaneous Coronary Intervention (PCI). They were divided to two equal groups according to concomitant COVID 19 infections diagnosed by Polymerase Chain Reaction (PCR). Group 1: Patients who presented by STEMI with concomitant COVID 19 infections diagnosed by positive PCR test and chest computerized tomography (CT). Group 2: Patients who presented with STEMI without COVID 19 infection diagnosed by negative PCR test and chest Computed Tomography (CT). Results

C-reactive protein (CRP), D-dimer levels are significant higher in the COVID group compared to the Non COVID group (p-value

Download

Share

COinS